Jenburkt Pharma - Quaterly Results

20 May 2025 Evaluate
The Revenue for the quarter ended  March 2025 of Rs. 410.47 millions grew by 5.68 % from Rs. 388.42 millions.A humble growth in net profit of 8.28% reported in the quarter ended March 2025 to Rs. 85.36  millions from Rs. 78.83 millions.The company reported a good operating profit of 127.37 millions compared to 110.42 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 410.47 388.42 5.68 1516.92 1419.66 6.85 1516.92 1419.66 6.85
Other Income 18.80 11.89 58.12 67.21 46.67 44.01 67.21 46.67 44.01
PBIDT 127.37 110.42 15.35 471.13 377.85 24.69 471.13 377.85 24.69
Interest 1.11 0.58 91.38 4.53 2.71 67.16 4.53 2.71 67.16
PBDT 126.26 109.84 14.95 466.60 375.14 24.38 466.60 375.14 24.38
Depreciation 7.91 6.18 27.99 27.28 23.40 16.58 27.28 23.40 16.58
PBT 118.35 103.66 14.17 439.32 351.74 24.90 439.32 351.74 24.90
TAX 32.99 24.83 32.86 118.72 91.98 29.07 118.72 91.98 29.07
Deferred Tax -2.79 -1.68 66.07 -2.06 -5.21 -60.46 -2.06 -5.21 -60.46
PAT 85.36 78.83 8.28 320.60 259.76 23.42 320.60 259.76 23.42
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 31.03 28.43 9.15 31.06 26.62 16.69 31.06 26.62 16.69

Jenburkt Pharma Share Price

1089.55 9.55 (0.88%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×